Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Pharm Biomed Anal. 2006 Mar 3;40(4):999-1005. Epub 2005 Sep 19.

Development and validation of a new HPLC method for determination of lamotrigine and related compounds in tablet formulations.

Author information

  • 1Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences/Isfahan Pharmaceutical Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran. emami@pharm.mui.ac.ir

Abstract

A simple HPLC method was developed and validated for quantitation of lamotrigine and its related substances which may coexist in solid pharmaceutical dosage forms. The HPLC separation was achieved on a C18 mu-Bondapack column (250 mm x 4.6 mm) using a mobile phase of acetonitrile-monobasic potassium phosphate solution (35:65, v/v) containing orthophosphoric acid to adjust pH to 3.5 at a flow rate of 1.5 ml/min. The UV detector was operated at 210 nm, and column temperature was adjusted at 40 degrees C. The method was validated for specificity, linearity, precision, accuracy, robustness and limit of quantitation. The degree of linearity of the calibration curves, the percent recoveries of lamotrigine and related substances, the limit of detection and quantitation, for the HPLC method were determined. The method was found to be simple, specific, precise, accurate, and reproducible. The method was applied for the quality control of commercial lamotrigine tablets to quantify the drug and its related substances and to check the formulation content uniformity.

PMID:
16176866
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk